Europe Dermatology Cro Market Size & Outlook, 2025-2033
Related Markets
Europe dermatology cro market highlights
- The Europe dermatology cro market generated a revenue of USD 947.8 million in 2024.
- The market is expected to grow at a CAGR of 4.7% from 2025 to 2033.
- In terms of segment, clinical was the largest revenue generating cro type in 2024.
- Preclinical is the most lucrative cro type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2025 to 2033.
Europe data book summary
| Market revenue in 2024 | USD 947.8 million |
| Market revenue in 2033 | USD 1,450.3 million |
| Growth rate | 4.7% (CAGR from 2025 to 2033) |
| Largest segment | Clinical |
| Fastest growing segment | Preclinical |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preclinical, Drug Discovery, Clinical |
| Key market players worldwide | IQVIA Holdings Inc, Labcorp Drug Development, Pharmaceutical Product Development, PAREXEL, Charles River Laboratories International Inc, Icon PLC, Medidata, Syneos Health, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Wuxi AppTec Co Ltd, Medpace Holdings Inc, CTI Clinical Trial and Consulting Services, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, Europe region accounted for 17.5% of the global dermatology cro market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,510.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatology CRO Market Scope
Dermatology CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CTI Clinical Trial and Consulting Services | View profile | 501-1000 | Covington, Kentucky, United States, North America | http://ctifacts.com |
| Medidata | View profile | 1001-5000 | New York, New York, United States, North America | https://www.medidata.com |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | https://ppd.com |
| Pharmaron Beijing Co Ltd Ordinary Shares - Class H | View profile | 20295 | No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, Hong Kong | https://www.pharmaron.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
Europe dermatology cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatology cro market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 80.16% in 2024. Horizon Databook has segmented the Europe dermatology cro market based on preclinical, drug discovery, clinical covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe dermatology cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe dermatology cro market databook
-
Our clientele includes a mix of dermatology cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dermatology cro market, including forecasts for subscribers. This continent databook contains high-level insights into Europe dermatology cro market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe dermatology cro market report size, by country, 2021-2033 (US$M)
Europe Dermatology CRO Market Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
